China News Service, January 8th (Reporter Chen Jing) The "Psoriasis" jointly compiled by more than 150 well-known experts in the field of psoriasis diagnosis, treatment and research in China was first released on the evening of the 8th. The first chapter of a series of monographs (a series of books).
It is reported that psoriasis, commonly known as "psoriasis", is an immune-inflammatory proliferative disease under the background of polygenic genetics, which seriously affects the quality of life of patients. It is the focus of global skin disease prevention and treatment research.
Psoriasis has a long history. Psoriasis was first discovered in Chaoyuan Fang of the Sui Dynasty in 610 AD. He called psoriasis "psoriasis" in "Theories of Disease Origins", which was recorded as early as 1200 years by foreign scholars.
"Vitiligo" first released.
Chen Jing
"Psoriasis" is edited by Professor Qin Wanzhang, the honorary chairman of the Chinese Society of Integrative Medicine, and the current chairman, Professor Gu Jun, to comprehensively summarize the research results of psoriasis in China in recent decades.
Chen Keji, academician of the Chinese Academy of Sciences, master of traditional Chinese medicine, and honorary president of the Chinese Integrative Medicine Association, introduced to reporters that the content of "Psoriasis" includes the research history of psoriasis, modern basic research, clinical treatment and traditional Chinese medicine treatment. It can be described as the "encyclopedia" of psoriasis.
Among them, the basic research and clinical treatment part is in line with international advanced technology and concepts; the traditional Chinese medicine part not only inherits the classic theories and proven prescriptions of Chinese medicine practitioners on psoriasis, but also explores the effect of traditional Chinese medicine innovation and research results on the treatment of psoriasis. For example, such as Tripterygium Glycoside Tablets, Kunxian Capsules, and White Peony Glycoside Tablets.
Chen Keji believes that the content of "Psoriasis" is based on domestic actual conditions and draws on current international advanced experience. Its publication will further standardize the treatment of psoriasis in China and bring good news to patients with psoriasis.
That night, another large-scale original academic monograph "Vitiligo" was released at the same time, which will expand the research results and influence of integrated Chinese and Western medicine in the diagnosis and treatment of vitiligo, improve the level of cognition, standardize clinical treatment, and better serve the majority of patients.
(Finish)